Table 2.

COVID-19 hospital admission rate and ORs in patients with inflammatory rheumatic diseases.

All Patientsa, nHospitalized Patients, nHospitalization Rate, %OR*95% CI*
Total population492,74523150.47
Non-IRD patients488,15322740.471.00
IRD patients4592410.891.911.41–2.61
RA1708160.942.011.23–3.28
SpA86230.350.740.24–2.31
PsA51540.781.660.63–4.43
SLE25441.573.381.28–8.95
Sjögren syndrome17542.294.901.86–12.94
Vasculitis16531.823.901.27–11.99
Inflammatory myopathy8811.142.430.35–17.13
PMR47461.272.711.23–6.02
Others351000
  • Values in bold are statistically significant.

  • a Hospitalized and nonhospitalized patients.

  • * Comparisons were between each disease group and no inflammatory rheumatic disease patients. COVID-19: coronavirus disease 2019; IRD: inflammatory rheumatic disease; PMR: polymyalgia rheumatica; PsA: psoriatic arthritis; RA: rheumatoid arthritis; SLE: systemic lupus erythematosus; SpA: spondyloarthritis.